Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 67, 2012 - Issue 5
48
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

A NATIONAL COHORT OF HIV-INFECTED PATIENTS IN BELGIUM: DESIGN AND MAIN CHARACTERISTICS

, , , , &
Pages 333-337 | Published online: 25 Jul 2014

REFERENCES

  • Infuso A, Hamers F, Downs AM, Alix J. HIV reporting in western Europe: national systems and first European data. Euro Surveill 2000; 5(2): 13–17.
  • Sasse A., Verbrugge R., Buzarsist J., Van Beckhoven D. Epidémiologie du SIDA et de l'infection a VIH en Belgique: Situation au 31 décembre 2009. Brussels: Scientific Institute of Public Health; 2010.
  • Sasse A, Van Der Heyden J, Stroobant A. Evolution of the HIV Epidemic in Bel-gium. Archives of Public health 1998; 56: 187–198.
  • Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338(13): 853–860.
  • Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol 2009; 38(5): 1202–1206.
  • The UK Collaborative HIV Cohort Steering Committee. The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med 2004; 5(2): 115–124.
  • Cohen CJ, lwane MK, Palensky JB, et al. A national HIV community cohort: design, baseline, and follow-up of the AmFAR Observational Database. Ameri-can Foundation for AIDS Research Community-Based Clinical Trials Network. J Clin Epidemiol 1998; 51(9): 779–793.
  • Ledergerber B, von Overbeck J, Egger M, Luthy R. The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed 1994; 39(6): 387–394.
  • Tassie JM, Gasnault J, Bentata M, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS 1999; 13(14): 1881–1887.
  • The Swiss HIV Cohort Study. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 2010; 39(5): 1179–1189.
  • Gras L, van Sighem A, Smit C, et al. Monitoring of human immunodeficiency virus (HIV) infection in the Netherlands. Report 2009. Amsterdam: Stichting HIV Monitoring; 2009.
  • Sasse A, Defraye A. HIV infections and STI co-infections in men who have sex with men in Belgium: sustained increase in HIV diagnoses. Euro Surveill 2009; 14(47).
  • Swiss HIV Cohort Study accessed at |http://www.shcs.ch/33-state-of-the-cohort, June 3 2011.
  • Clumeck N, Pozniak A, Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med 2008; 9(2): 65–71.
  • Easterbrook PJ, Phillips AN, Hill T, et al. Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK. HIV Med 2008; 9(1): 47–56.
  • Reekie J, Mocroft A, Sambatakou H, et al. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure? AIDS 2008; 22(17): 2381–2390.
  • European AIDS Clinical Society. European guidelines for the clinical management and treatment of HIV infected adults 2005.
  • Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296(7): 827–843.
  • Hammer SM, Eron JJ, Jr., Reiss P, et al. Antiretroviral treatment of adult HIV infec-tion: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300(5): 555–570.
  • Stohr W, Dunn D, Porter K, et al. CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. H/VMed 2007; 8(3): 135–141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.